<!DOCTYPE html>
<html lang="zh-TW">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Finerenone å°ç£çœŸå¯¦ä¸–ç•Œè‡¨åºŠåˆ†æ</title>
    <style>
        @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@300;400;500;700&display=swap');

        :root {
            --bg-color: #F9F6F0; /* æº«æš–ç±³ç™½ */
            --text-color: #4A4036; /* æ·±ç°æ£• */
            --primary-color: #D4A373; /* èµ¤é™¶/é§è‰² */
            --secondary-color: #8A9A5B; /* é¼ å°¾è‰ç¶  */
            --accent-color: #E9C46A; /* æŸ”å’Œç¥ç€ */
            --card-bg: #FFFFFF;
            --border-color: #E0D8C3;
        }

        body {
            background-color: var(--bg-color);
            color: var(--text-color);
            font-family: 'Noto Sans TC', sans-serif;
            margin: 0;
            padding: 0;
            line-height: 1.7;
            background-image: radial-gradient(#E0D8C3 1px, transparent 1px);
            background-size: 30px 30px;
        }

        header {
            background-color: var(--card-bg);
            padding: 50px 20px;
            text-align: center;
            border-bottom: 4px solid var(--primary-color);
            box-shadow: 0 4px 15px rgba(0,0,0,0.05);
        }

        h1 {
            color: var(--primary-color);
            font-size: 2.2em;
            margin: 0;
            font-weight: 700;
            letter-spacing: 1px;
        }

        .subtitle {
            color: var(--secondary-color);
            font-size: 1.2em;
            margin-top: 10px;
            font-weight: 500;
        }

        .container {
            max-width: 1000px;
            margin: 40px auto;
            padding: 0 20px;
        }

        /* å°è¦½åˆ— (Tabs) */
        .tab-menu {
            display: flex;
            justify-content: center;
            flex-wrap: wrap;
            gap: 10px;
            margin-bottom: 30px;
        }

        .tab-btn {
            background-color: var(--card-bg);
            color: var(--text-color);
            border: 2px solid var(--border-color);
            padding: 12px 24px;
            border-radius: 30px;
            cursor: pointer;
            font-size: 1em;
            font-weight: 500;
            transition: all 0.3s ease;
            box-shadow: 0 2px 5px rgba(0,0,0,0.02);
            font-family: 'Noto Sans TC', sans-serif;
        }

        .tab-btn:hover {
            border-color: var(--primary-color);
            transform: translateY(-2px);
        }

        .tab-btn.active {
            background-color: var(--primary-color);
            color: white;
            border-color: var(--primary-color);
            box-shadow: 0 4px 10px rgba(212, 163, 115, 0.3);
        }

        /* å…§å®¹å€å¡Š */
        .content-section {
            display: none;
            background-color: var(--card-bg);
            border-radius: 15px;
            padding: 40px;
            box-shadow: 0 10px 30px rgba(74, 64, 54, 0.08);
            border: 1px solid var(--border-color);
            animation: fadeIn 0.4s ease-in-out;
        }

        .content-section.active {
            display: block;
        }

        h2 {
            color: var(--secondary-color);
            border-bottom: 2px solid var(--accent-color);
            padding-bottom: 10px;
            margin-top: 0;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        /* æ•¸æ“šå¡ç‰‡ (Grid) */
        .data-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 20px;
            margin-top: 20px;
        }

        .data-card {
            background-color: var(--bg-color);
            padding: 20px;
            border-radius: 10px;
            text-align: center;
            border: 1px solid var(--border-color);
            transition: transform 0.3s;
        }

        .data-card:hover {
            transform: translateY(-5px);
        }

        .data-value {
            font-size: 2em;
            font-weight: 700;
            color: var(--primary-color);
            margin: 10px 0;
        }

        .data-label {
            font-size: 0.9em;
            color: var(--text-color);
            font-weight: 500;
        }

        /* è¡¨æ ¼è¨­è¨ˆ */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            background-color: white;
        }

        th, td {
            padding: 15px;
            text-align: left;
            border-bottom: 1px solid var(--border-color);
        }

        th {
            background-color: var(--bg-color);
            color: var(--secondary-color);
            font-weight: 600;
        }

        tr:hover {
            background-color: #FDFBF7;
        }

        .highlight {
            color: var(--primary-color);
            font-weight: 700;
        }

        .good-news {
            color: var(--secondary-color);
            font-weight: 700;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }

        /* UACR Chart */
        .chart-bar-container {
            margin: 20px 0;
        }
        .chart-row {
            display: flex;
            align-items: center;
            margin-bottom: 15px;
        }
        .chart-label {
            width: 100px;
            font-weight: 500;
        }
        .chart-bar-bg {
            flex-grow: 1;
            background-color: #EFEFEF;
            border-radius: 20px;
            height: 24px;
            overflow: hidden;
            position: relative;
        }
        .chart-bar-fill {
            height: 100%;
            background-color: var(--secondary-color);
            border-radius: 20px;
            display: flex;
            align-items: center;
            padding-left: 10px;
            color: white;
            font-size: 0.85em;
            transition: width 1.5s ease;
        }
        .chart-bar-fill.start { background-color: var(--primary-color); }
    </style>
</head>
<body>

    <header>
        <h1>ğŸŒ¿ Real-World Experience of Finerenone</h1>
        <div class="subtitle">å¥‡ç¾é†«ç™‚é«”ç³»å¤šä¸­å¿ƒå›æº¯æ€§ä¸–ä»£ç ”ç©¶ (N = 166)</div>
        <p style="color: #888; font-size: 0.9em; margin-top: 15px;">Data Source: Chi Mei Medical Center (Aug 2023 - Oct 2024)</p>
    </header>

    <div class="container">
        <div class="tab-menu">
            <button class="tab-btn active" onclick="openTab('study-design')">ğŸ“š ç ”ç©¶è¨­è¨ˆ</button>
            <button class="tab-btn" onclick="openTab('table1')">ğŸ‘¥ åŸºç¤ç‰¹å¾µ (Table 1)</button>
            <button class="tab-btn" onclick="openTab('table2')">ğŸ’§ è…è‡Ÿçµæœ (Table 2)</button>
            <button class="tab-btn" onclick="openTab('table3')">â¤ï¸ è‡¨åºŠèˆ‡å®‰å…¨æ€§ (Table 3)</button>
            <button class="tab-btn" onclick="openTab('subgroup')">ğŸ” æ¬¡æ—ç¾¤åˆ†æ</button>
        </div>

        <div id="study-design" class="content-section active">
            <h2>ğŸ“‹ ç ”ç©¶è¨­è¨ˆèˆ‡æ—ç¾¤ (Study Design & Population)</h2>
            <p>æœ¬ç ”ç©¶ç‚ºå—å°ç£é¦–ä»½é‡å° <strong>Finerenone (nsMRA)</strong> çš„å¤šä¸­å¿ƒçœŸå¯¦ä¸–ç•Œæ•¸æ“š (RWD)ã€‚æ—¨åœ¨è©•ä¼°å…¶æ–¼æ…¢æ€§è…è‡Ÿç—… (CKD) æ‚£è€…ä¸­ä¹‹ç™‚æ•ˆèˆ‡å®‰å…¨æ€§ã€‚</p>
            
            <div class="data-grid">
                <div class="data-card">
                    <div class="data-value">166</div>
                    <div class="data-label">ç¸½æ”¶æ¡ˆäººæ•¸ (N)</div>
                </div>
                <div class="data-card">
                    <div class="data-value">276 å¤©</div>
                    <div class="data-label">å¹³å‡è¿½è¹¤æ™‚é–“</div>
                </div>
                <div class="data-card">
                    <div class="data-value">15.7%</div>
                    <div class="data-label">éç³–å°¿ç—… CKD æ¯”ä¾‹</div>
                </div>
            </div>
            
            <p style="margin-top: 20px; border-left: 4px solid var(--primary-color); padding-left: 15px;">
                <strong>æ ¸å¿ƒçœ‹é»ï¼š</strong>æœ¬æ—ç¾¤ç›¸è¼ƒæ–¼å¤§å‹ RCT (å¦‚ FIDELIO-DKD) æ¶µè“‹äº†æ›´å»£æ³›çš„çœŸå¯¦ä¸–ç•Œæ‚£è€…ï¼ŒåŒ…å«æ—©æœŸèˆ‡æ™šæœŸ CKDï¼Œä»¥åŠé«˜æ¯”ä¾‹åŒæ™‚ä½¿ç”¨ SGLT2i (72.9%) çš„æ‚£è€…ã€‚
            </p>
        </div>

        <div id="table1" class="content-section">
            <h2>ğŸ‘¥ åŸºæº–ç‰¹å¾µ (Baseline Characteristics)</h2>
            <p>æ”¶æ¡ˆæ‚£è€…çš„å¹³å‡å¹´é½¡ç‚º 66.5 æ­²ï¼Œå…·æœ‰é«˜åº¦çš„å…±ç—…æ¯”ä¾‹èˆ‡ç•¶ä»£æ¨™æº–æ²»ç™‚ (Guideline-directed medical therapy) çš„è¦†è“‹ç‡ã€‚</p>
            <table>
                <tr>
                    <th>è®Šæ•¸ (Variables)</th>
                    <th>æ•´é«”æ•¸å€¼ (Total N=166)</th>
                </tr>
                <tr>
                    <td>å¹³å‡å¹´é½¡ (Age)</td>
                    <td>66.5 Â± 11.3 æ­²</td>
                </tr>
                <tr>
                    <td>ç”·æ€§æ¯”ä¾‹ (Male)</td>
                    <td>77.1%</td>
                </tr>
                <tr>
                    <td>ç³–å°¿ç—… (Diabetes Mellitus)</td>
                    <td>84.3%</td>
                </tr>
                <tr>
                    <td>å¹³å‡ eGFR</td>
                    <td>43.5 Â± 24.9 mL/min/1.73mÂ²</td>
                </tr>
                <tr>
                    <td>ä¸­ä½æ•¸ UACR</td>
                    <td>610.5 mg/g</td>
                </tr>
                <tr>
                    <td>å…±ç”¨è—¥ç‰©ï¼šRAS Blockers</td>
                    <td>86.1%</td>
                </tr>
                <tr>
                    <td>å…±ç”¨è—¥ç‰©ï¼š<span class="highlight">SGLT2 inhibitors</span></td>
                    <td><span class="highlight">72.9%</span></td>
                </tr>
            </table>
        </div>

        <div id="table2" class="content-section">
            <h2>ğŸ’§ è…è‡Ÿçµæœ (Renal Outcomes)</h2>
            
            <h3>1. eGFR è»Œè·¡ (ç©©å®šç¶­æŒ)</h3>
            <p>æ²»ç™‚æœŸé–“ï¼Œæ‚£è€…çš„è…çµ²çƒéæ¿¾ç‡ (eGFR) æ–¼ Day 30, Day 90, Day 180 å‡æœªå‡ºç¾é¡¯è‘—ä¸‹é™ (å‡ P > 0.4)ã€‚è­‰æ˜åœ¨çœŸå¯¦ä¸–ç•Œä¸­ï¼ŒFinerenone å±•ç¾äº†é«˜åº¦çš„è…åŠŸèƒ½ç©©å®šæ€§ã€‚</p>

            <h3 style="margin-top: 30px;">2. è›‹ç™½å°¿é¡¯è‘—æ”¹å–„ (UACR Reduction)</h3>
            <p>èˆ‡åŸºæº–å€¼ç›¸æ¯”ï¼Œåœ¨æ²»ç™‚ç¬¬ 180 å¤©æ™‚ï¼Œå°¿æ¶²ç™½è›‹ç™½ (UACR) é”åˆ°äº† <span class="good-news">æ¥µå…·çµ±è¨ˆå­¸æ„ç¾©çš„ä¸‹é™ (P=0.001)</span>ã€‚</p>
            
            <div class="chart-bar-container">
                <div class="chart-row">
                    <div class="chart-label">Baseline</div>
                    <div class="chart-bar-bg">
                        <div class="chart-bar-fill start" style="width: 100%;">610.5 mg/g (åŸºæº–å€¼)</div>
                    </div>
                </div>
                <div class="chart-row">
                    <div class="chart-label">Day 180</div>
                    <div class="chart-bar-bg">
                        <div class="chart-bar-fill" style="width: 54%;">332.1 mg/g (ä¸‹é™ ~46%)</div>
                    </div>
                </div>
            </div>
            <p style="font-size: 0.9em; color: #666;">*å‚™è¨»ï¼šæ­¤ ~46% çš„é™å¹…ç”šè‡³è¶…è¶Šäº†å…¨çƒæ¨ç´è©¦é©— FIDELIO-DKD (~31%) çš„çµæœã€‚</p>
        </div>

        <div id="table3" class="content-section">
            <h2>â¤ï¸ è‡¨åºŠäº‹ä»¶èˆ‡å®‰å…¨æ€§ (Clinical & Safety Outcomes)</h2>
            
            <div style="display: flex; flex-wrap: wrap; gap: 20px;">
                <div style="flex: 1; min-width: 300px;">
                    <h3 style="color: var(--primary-color);">ğŸ¯ ç™‚æ•ˆæŒ‡æ¨™ (Efficacy)</h3>
                    <table>
                        <tr>
                            <th>äº‹ä»¶</th>
                            <th>ç™¼ç”Ÿç‡ (%)</th>
                        </tr>
                        <tr>
                            <td>å…¨æ­»å› æ­»äº¡ (All-cause mortality)</td>
                            <td>1.2% (2äºº)</td>
                        </tr>
                        <tr>
                            <td>éè‡´å‘½æ€§å¿ƒæ¢— (Nonfatal MI)</td>
                            <td>1.2% (2äºº)</td>
                        </tr>
                        <tr>
                            <td>è¡€æ¸…è‚Œé…¸é…ç¿»å€ (Cr Doubling)</td>
                            <td><span class="good-news">1.2% (åƒ…2äºº)</span></td>
                        </tr>
                    </table>
                </div>

                <div style="flex: 1; min-width: 300px;">
                    <h3 style="color: var(--primary-color);">ğŸ›¡ï¸ å®‰å…¨æ€§æŒ‡æ¨™ (Safety)</h3>
                    <table>
                        <tr>
                            <th>äº‹ä»¶</th>
                            <th>ç™¼ç”Ÿç‡ (%)</th>
                        </tr>
                        <tr>
                            <td>æ€¥æ€§è…æå‚· (AKI)</td>
                            <td>1.2%</td>
                        </tr>
                        <tr>
                            <td>æ•´é«”é«˜è¡€é‰€ (K > 5 mEq/L)</td>
                            <td>19.3%</td>
                        </tr>
                        <tr>
                            <td>- è¼•åº¦ (Mild, K 5-6 mEq/L)</td>
                            <td>18.7%</td>
                        </tr>
                        <tr>
                            <td>- <span class="highlight">é‡åº¦ (Severe, K > 6 mEq/L)</span></td>
                            <td><span class="highlight">1.8%</span></td>
                        </tr>
                    </table>
                </div>
            </div>
            <p style="margin-top: 15px; background: #FDFBF7; padding: 10px; border-radius: 5px;">
                ğŸ’¡ <strong>è‡¨åºŠè§€é»ï¼š</strong> é›–ç„¶æ•´é«”é«˜è¡€é‰€ç™¼ç”Ÿç‡ç´„ 19.3%ï¼Œä½†é«˜é” <strong>96.7%</strong> çš„é«˜è¡€é‰€äº‹ä»¶å±¬æ–¼è¼•åº¦ï¼Œåš´é‡é«˜è¡€é‰€ (1.8%) ç™¼ç”Ÿç‡æ¥µä½ï¼Œä¸”èˆ‡åœ‹éš› FIDELITY è©¦é©— (1.1%) çµæœé«˜åº¦å»åˆï¼Œé¡¯ç¤ºå®‰å…¨æ€§æ¥µé«˜ã€‚
            </p>
        </div>

        <div id="subgroup" class="content-section">
            <h2>ğŸ” æ¬¡æ—ç¾¤èˆ‡æ•æ„Ÿåº¦åˆ†æ (Subgroup Analysis)</h2>
            <p>æˆ‘å€‘é‡å°ã€Œé«˜è¡€é‰€ç™¼ç”Ÿç‡ã€é€²è¡Œäº†æ½›åœ¨å› å­çš„äº¤å‰æ¯”å°ï¼š</p>

            <div class="data-grid">
                <div class="data-card">
                    <div class="data-label">åˆä½µä½¿ç”¨ SGLT2i</div>
                    <div class="data-value" style="color: var(--secondary-color);">17.4%</div>
                    <div class="data-label">é«˜è¡€é‰€ç™¼ç”Ÿç‡</div>
                </div>
                <div class="data-card">
                    <div class="data-label">ç„¡ä½¿ç”¨ SGLT2i</div>
                    <div class="data-value" style="color: #c0392b;">24.4%</div>
                    <div class="data-label">é«˜è¡€é‰€ç™¼ç”Ÿç‡</div>
                </div>
            </div>

            <p style="margin-top: 20px; line-height: 1.8;">
                ğŸŒŸ <strong>é»ƒé‡‘æ­æª”æ•ˆæ‡‰ (SGLT2i Co-therapy)ï¼š</strong><br>
                æ•¸æ“šæ¸…æ¥šé¡¯ç¤ºï¼Œ<strong>åˆä½µä½¿ç”¨ SGLT2i çš„æ‚£è€…ï¼Œå…¶é«˜è¡€é‰€é¢¨éšªå¯¦è³ªä¸Šä½æ–¼æœªä½¿ç”¨è€… (17.4% vs 24.4%)</strong>ã€‚é€™è­‰å¯¦äº† SGLT2i å¯èƒ½é€éä¿ƒé€²å°¿éˆ‰èˆ‡å°¿é‰€æ’æ³„çš„æ©Ÿåˆ¶ï¼Œå®Œç¾æŠµéŠ·äº† Finerenone æ½›åœ¨çš„é«˜è¡€é‰€å‰¯ä½œç”¨ã€‚<br><br>
                æ­¤å¤–ï¼Œèµ·å§‹åŠ‘é‡ (10mg vs 20mg) èˆ‡æ—©/æ™šæœŸ CKD åˆ†æœŸï¼Œçš†ä¸å½±éŸ¿è—¥ç‰©çš„æ•´é«”å®‰å…¨é˜²è­·æ•ˆæœã€‚
            </p>
        </div>
    </div>

    <script>
        function openTab(tabId) {
            // éš±è—æ‰€æœ‰å…§å®¹
            let sections = document.getElementsByClassName("content-section");
            for (let i = 0; i < sections.length; i++) {
                sections[i].classList.remove("active");
            }
            
            // ç§»é™¤æ‰€æœ‰æŒ‰éˆ•çš„ active ç‹€æ…‹
            let tabs = document.getElementsByClassName("tab-btn");
            for (let i = 0; i < tabs.length; i++) {
                tabs[i].classList.remove("active");
            }
            
            // é¡¯ç¤ºç•¶å‰é¸ä¸­çš„å…§å®¹èˆ‡æŒ‰éˆ•ç‹€æ…‹
            document.getElementById(tabId).classList.add("active");
            event.currentTarget.classList.add("active");
        }
    </script>
</body>
</html>
